# Clinical Trial of GX-I7 in Healthy Volunteers

> **NCT02860715** · PHASE1 · COMPLETED · sponsor: **Genexine, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GX-I7
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02860715
- **Lead sponsor:** Genexine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-11
- **Primary completion:** 2017-01-20
- **Final completion:** 2018-06-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02860715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02860715, "Clinical Trial of GX-I7 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02860715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*